Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junan Li

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
CPT: Pharmacometrics & Systems Pharmacology|October 22, 2018
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell TransplantYu Kyoung Cho, Donald J Irby, Junan Li, et al.
Bioorganic & Medicinal Chemistry|September 17, 2024
N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitorsChris La Rosa, Pankaj Sharma, M Junaid Dar, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Cancer Research Communications|March 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia SusceptibilityHanieh Taheri, Yang Li, Kevin M Huang, et al.
Nature Communications|November 1, 2024
CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azolesYiru Jin, Somrita Basu, Mei Feng, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
CPT: Pharmacometrics & Systems Pharmacology|October 22, 2018
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell TransplantYu Kyoung Cho, Donald J Irby, Junan Li, et al.
Bioorganic & Medicinal Chemistry|September 17, 2024
N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitorsChris La Rosa, Pankaj Sharma, M Junaid Dar, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Cancer Research Communications|March 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia SusceptibilityHanieh Taheri, Yang Li, Kevin M Huang, et al.
Nature Communications|November 1, 2024
CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azolesYiru Jin, Somrita Basu, Mei Feng, et al.
Pageof 12